/AFME.PA
AFME.PA Stock - Affluent Medical S.A.
Healthcare|Medical - DevicesPAR
$2.19+8.96%
+$0.18 (+8.96%) • Dec 23
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.92
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.41
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AFME.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.17 – $2.21
TARGET (TP)$2.52
STOP LOSS$2.01
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.70
52W High$2.23
52W Low$1.16
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.12M | $1.22M | $1.34M | $1.45M | $824,000 |
| Gross Profit | $-9,272,000 | $-1,200,000 | $-1,104,000 | $-1,290,000 | $-2,436,000 |
| Gross Margin | -225.2% | -98.0% | -82.4% | -88.9% | -295.6% |
| Operating Income | $-15,689,000 | $-13,066,000 | $-11,883,000 | $-13,233,000 | $-12,992,000 |
| Net Income | $-14,739,000 | $-15,653,000 | $-15,227,000 | $-14,820,000 | $-14,319,000 |
| Net Margin | -357.9% | -1278.8% | -1137.2% | -1021.4% | -1737.7% |
| EPS | $-0.37 | $-0.54 | $-0.81 | $-0.80 | $-0.77 |
Company Overview
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AFME.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.14
Q4 2024
EPS Surprise History
Q3 21
No data
Q2 22
No data
Q3 22
No data
Q2 23
No data
Q3 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.14 | — | — |
Q3 2024 | Sep 13, 2024 | — | $-0.29 | — | — |
Q2 2024 | Apr 25, 2024 | — | $-0.25 | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.26 | — | — |
Q2 2023 | May 3, 2023 | — | $-0.36 | — | — |
Q3 2022 | Sep 28, 2022 | — | $-0.44 | — | — |
Q2 2022 | May 1, 2022 | — | $-0.39 | — | — |
Q3 2021 | Sep 22, 2021 | — | $-0.41 | — | — |
Q2 2021 | Apr 14, 2021 | — | $-0.50 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.58 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.45 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.45 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.36 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.36 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.24 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.24 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AFME.PA
What is AFME.PA's current stock price?
Affluent Medical S.A. (AFME.PA) is currently trading at $2.19 per share. The stock has moved +8.96% today.
What is the analyst price target for AFME.PA?
No analyst price targets are currently available for this stock.
What sector is Affluent Medical S.A. in?
Affluent Medical S.A. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the PAR exchange.
What is AFME.PA's market cap?
Affluent Medical S.A. has a market capitalization of $0.09 billion, making it a small-cap company.
Does AFME.PA pay dividends?
No, Affluent Medical S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAB.PA
AB Science S.A.
$1.35
Mkt Cap: $0.1B
ALDMS.PA
Diagnostic Medical Systems S.A.
$1.27
Mkt Cap: $0.0B
ALGAE.PA
Fermentalg
$0.42
Mkt Cap: $0.0B
ALIKO.PA
Ikonisys S.A.
$1.64
Mkt Cap: $0.0B
ALIMP.PA
Implanet S.A.
$0.19
Mkt Cap: $0.0B
ALKLH.PA
Klea Holding
$0.23
Mkt Cap: $0.1B
ALMDT.PA
Median Technologies S.A.
$4.42
Mkt Cap: $0.2B
ALNOV.PA
Novacyt S.A.
$0.42
Mkt Cap: $0.0B
ALTHE.PA
Theraclion S.A.
$0.57
Mkt Cap: $0.0B
MAAT.PA
MaaT Pharma S.A.
$4.14
Mkt Cap: $0.1B
Explore stocks similar to AFME.PA for comparison